The Discounted Cash Flow (DCF) valuation of Knight Therapeutics Inc (GUD.TO) is 0.62 CAD. With the latest stock price at 5.33 CAD, the upside of Knight Therapeutics Inc based on DCF is -88.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.3% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.34 - 3.62 | 0.62 |
| Upside | -93.6% - -32.1% | -88.3% |